← USPTO Patent Applications

Differential Knockout of an Allele of a Heterozygous Elane Gene

Application US20260078415A1 Kind: A1 Mar 19, 2026

Inventors

David BARAM, Lior IZHAR, Asael HERMAN, Rafi EMMANUEL, Michal GOLAN MASHIACH, Joseph GEORGESON

Abstract

Methods for inactivating in a cell a mutant allele of the elastase, neutrophil expressed gene (ELANE gene) gene having a mutation associated with severe congenital neutropenia (SCN) or cyclic neutropenia (CyN) and which cell is heterozygous at one or more polymorphic sites selected from the group consisting of: rs10414837, rs3761005, rs1683564, rs9749274, rs740021, rs201048029, rs199720952, rs28591229, rs71335276, rs58082177, rs3826946, rs10413889, rs761481944, rs3761008, rs10409474, rs3761007, rs17216649, rs10469327, rs8107095, rs10424470 and rs78302854, the method comprising introducing to the cell a composition comprising: a CRISPR nuclease or a sequence encoding the CRISPR nuclease; anda first RNA molecule comprising a guide sequence portion having 17-20 nucleotides,wherein a complex of the CRISPR nuclease and the first RNA molecule affects a double strand break in the mutant allele of the ELANE gene, the method optionally further comprising introduction of a second RNA molecule comprising a guide sequence portion capable of complexing with a CRISPR nuclease, wherein the complex of the second RNA molecule and CRISPR nuclease affects a second double strand break in the ELANE gene.

CPC Classifications

C12N 15/907 A61K 35/28 C12N 9/22 C12N 15/11 C12Q 1/6883 C12N 2310/20 C12N 2800/80 C12Q 2600/106

Filing Date

2025-11-24

Application No.

19398868